(1997). Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. Bmj..
(1999). A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol..
(1998). Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review. Drug Saf..
(2002). Risk of serious skin disorders among users of oral antifungals: a population-based study. BMC Dermatol..
(2005). Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. http://doi.org/10.1053/j.ajkd.2004.12.005.
(2006). Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart. http://doi.org/10.1136/hrt.2005.082388.
(2018). Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study. Drugs Real World Outcomes. http://doi.org/10.1007/s40801-018-0133-1.
(2018). GOLD assessment of COPD severity in the Clinical Practice Research Datalink (CPRD). Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.4448.
(2018). A cohort study on the risk of lymphoma and skin cancer in users of topical tacrolimus, pimecrolimus, and corticosteroids (Joint European Longitudinal Lymphoma and Skin Cancer Evaluation - JOELLE study). Clin Epidemiol. http://doi.org/10.2147/clep.s146442.
(2019). Use of aclidinium did not increase the risk of death in a noninterventional cohort study in the Clinical Practice Research Datalink (CPRD), United Kingdom. Respir Med. http://doi.org/10.1016/j.rmed.2019.04.018.